by Richard Daverman, PhD
February 6, 2013 -- Cardinal Health, a major US drug distributor, says it has spent $120 million to acquire six China drug distributors during the last year, paying less than $30 million for each one. Cardinal’s CFO Jeff Henderson said the goal with each transaction was not revenue volume but greater geographical reach. The acquisition targets were not named. In 2010, Cardinal made a dramatic entry in China’s drug distribution sector by purchasing Zuellig China for $458 million. More details....
Stock Symbol: (NYSE: CAH)
